Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protease inhibitor SERPINA1 expression in epithelial ovarian cancer.
Normandin K, Péant B, Le Page C, de Ladurantaye M, Ouellet V, Tonin PN, Provencher DM, Mes-Masson AM. Normandin K, et al. Among authors: de ladurantaye m. Clin Exp Metastasis. 2010;27(1):55-69. doi: 10.1007/s10585-009-9303-6. Epub 2010 Jan 5. Clin Exp Metastasis. 2010. PMID: 20049513
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.
Wojnarowicz PM, Oros KK, Quinn MC, Arcand SL, Gambaro K, Madore J, Birch AH, de Ladurantaye M, Rahimi K, Provencher DM, Mes-Masson AM, Greenwood CM, Tonin PN. Wojnarowicz PM, et al. Among authors: de ladurantaye m. PLoS One. 2012;7(9):e45484. doi: 10.1371/journal.pone.0045484. Epub 2012 Sep 20. PLoS One. 2012. PMID: 23029043 Free PMC article.
VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer.
Gambaro K, Quinn MC, Wojnarowicz PM, Arcand SL, de Ladurantaye M, Barrès V, Ripeau JS, Killary AM, Davis EC, Lavoie J, Provencher DM, Mes-Masson AM, Chevrette M, Tonin PN. Gambaro K, et al. Among authors: de ladurantaye m. Mol Oncol. 2013 Jun;7(3):513-30. doi: 10.1016/j.molonc.2012.12.006. Epub 2013 Jan 16. Mol Oncol. 2013. PMID: 23415753 Free PMC article.
BMP-2 signaling in ovarian cancer and its association with poor prognosis.
Le Page C, Puiffe ML, Meunier L, Zietarska M, de Ladurantaye M, Tonin PN, Provencher D, Mes-Masson AM. Le Page C, et al. Among authors: de ladurantaye m. J Ovarian Res. 2009 Apr 14;2:4. doi: 10.1186/1757-2215-2-4. J Ovarian Res. 2009. PMID: 19366455 Free PMC article.
Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease.
Sauriol SA, Simeone K, Portelance L, Meunier L, Leclerc-Desaulniers K, de Ladurantaye M, Chergui M, Kendall-Dupont J, Rahimi K, Carmona E, Provencher DM, Mes-Masson AM. Sauriol SA, et al. Among authors: de ladurantaye m. Cancers (Basel). 2020 Aug 8;12(8):2222. doi: 10.3390/cancers12082222. Cancers (Basel). 2020. PMID: 32784519 Free PMC article.
Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer.
Elkholi IE, Di Iorio M, Fahiminiya S, Arcand SL, Han H, Nogué C, Behl S, Hamel N, Giroux S, de Ladurantaye M, Aleynikova O, Gotlieb WH, Côté JF, Rousseau F, Tonin PN, Provencher D, MesMasson AM, Akbari MR, Rivera B, Foulkes WD. Elkholi IE, et al. Among authors: de ladurantaye m. Sci Rep. 2021 Jan 28;11(1):2409. doi: 10.1038/s41598-021-81106-w. Sci Rep. 2021. PMID: 33510186 Free PMC article.
20 results